INTRODUCTION
Red blood cell metabolism provides the cell with energy in the form of adenosine triphosphate (ATP) to pump ions against electrochemical gradients, maintain its shape, keep iron from haemoglobin in the reduced form and maintain enzyme and haemoglobin sulfhydryl groups. The main source of metabolic enzyme comes from glucose. Glucose is metabolized through the Embden-Meyerhof glycolytic pathway through the Hexose Monophosphate shunt (HMP) to produce adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NADH), 2,3, -bisphosphoglycerate, an important regulator of the oxygen affinity of haemoglobin [1] .
During the process in the glycolytic pathway, Glucose-6-phosphate dehydrogenase is an important enzyme that catalizes catalyzes the oxidation of glucose, that is, the oxygen ultilisation of red blood cells (RBCs) and help in maintaining the normal life span of red blood cells [1] . To achieve this, the hexose monophosphate shunt (HMS) oxidize glucose -6-phosphate in the presence of the enzyme (G6PD), thereby generating nicotinamide adenine dinucleoside phosphate (NADPH) which serves the red cells to maintain high concentration of reduced glutathione (GSH) and the red cells are protected from oxidants, with 5-10% of the glucose metabolized [2] .
Glucose -6-phosphate dehydrogenase (G6PD) is an X-linked chromosomal inheritance [2] . Thus, mutation of the gene in the X-chromosome or any factor that can lead to the defects of the gene causing deficiency of the enzyme (G6PD).Glucose -6-phosphate dehydrogenase deficiency is an X-linked chromosomal disorder and a high polymorphic enzyme affecting about 400 million people worldwide. The enzyme gene involved is located on the long arm of the X-chromosome Xq28 [3] . The resultant effect of the deficiency is the destruction of the red blood cells (RBCs) thereby given rise to the episode of haemolyticanaemia, characterized by the physical signs and symptoms of jaundice with haemolysis of red cells seen in susceptible individuals [2] .
Glucose-6-phosphate dehydrogenase deficiency is the most common enzymopathy in humans. It is triggered by predisposing biological agent, such as bacteria and virus infections with other environmental factors such as drugs used for the treatment of malaria infection (e.g. quinine) and consumption of fava beans or inhalation of pollen from fava bean plants by those exposed to the plant. Exposure to any of these factors in association with the deficiency of the enzyme increases the breakdown of RBCs in vulnerable individuals. Thus leading to haemolysis and condition known as favism [3] .
Hereditary deficiency of red blood cell glucose-6-phosphate dehydrogenase (G6PD) is associated with clinical manifestations like drug-induced haemolytic anaemia, neonatal jaundice, favism, non-spherocytic congenital haemolytic anaemia [2] ; [4] . The drug-induced haemolytic anemia associated with G6PD deficiency has an increased frequency of occurrence in some population due to high prevalence of malaria in those areas eg. Asia, Mediterranean and Africa, non-spherocytic congenital haemolytic anaemia occur mainly by involving the Embden-Meyerhof or hexose monophosphate pathway [ 5] ..
Reactive oxygen species (R0S) such as super oxide, hydrogen peroxide, hydroxyl radical, cause oxidative stress and damage of cells membrane [6] ; [7] . Increase production of ROS or decrease antioxidative defense enzymes play a major role in oxidative injuries in different organs, tissues, and cells including brain, heart, vascular cells [6] , and causes brain disease like Alzheimer and Parkinson disease. They are considered to contribute to the aging process [8] ; [7] . Glucose-6-phosphate dehydrogenase, superoxide dismutases, catalase, glutathione peroxidases and glutathione reductase and are antioxidant defense enzymes. In the human body, antioxidant defense system G6PD is an essential modulator enzyme with significant role in cells (red blood cells) [6] .
The G6PD functions in maintenance of redox potential in cell producing NADPH in pentose phosphate pathway [6] , and also in controlling of cell death.
MATERIAL AND METHODS

Study Design
Cross sectional non-randomized study was conducted to determine the prevalence of G6PD deficiency in Ogoni and Etche ethnic groups in Rivers State.
Study Area
The study was conducted within the Ogonis located at the south-East Nigeria, coast of the Gulf of Guinea, east of the city of Port Harcourt, River State. It extends across the local government area (LGA) of Khana, Gokana, Eleme, and Tai with a total population over 500,000, living in a 404-square-mile (1,050 kilo mitres). 
Study Population
The G6PD deficiency individuals tested were people from Ogoni and Etche ethnic group, with study population of two hundred (200) subjects, One hundred (100) subjects from Ogoni and one hundred (100) subjects from Etche region. The research was conducted between March and August 2018.
Eligibility Criteria
The criteria for eligibility are that all the people from Ogoni and Etche are eligible, irrespective of age and gender. Non-Ogoni and Etche indigenes are totally excluded. Informed consent was obtained from subjects who were apparently healthy prior to enrolment. Ethical clearance was given by the Ethics Committee of the Department of Medical Laboratory Science, Rivers State University.
Sample Collection
Three (3) milliliters of blood were collected from each subject using a standard technique described for sample collection through venipuncture from the anticubital vein and dispensed into a labeled ethylenediaminetetracetic (EDTA) container capable of containing 10 mls of blood with a concentration of 1.5 mls of EDTA. The sample obtained was transported under heat-insulated envelopes and refrigerated stable transport container within 48 hours of collection to the Haematology Laboratory of Department of Medical Laboratory Science River State University and analyzed.
Sample Analysis
The method used for determination of Glucose-6-phosphate Dehydrogenase was by Spectrophotometry at wavelength 340nm was employed as described by RANDOX Laboratory Ltd.
The principle is based on the evaluation of absorbance at 340nm given by NADH formation, the quantitative evaluation is made by adding a precise amount of haemolysate to an assay mixture containing the substrate G6P and its cofactor NADP, the rate of NADP generation is spectrophotometrically measured at wavelength of 340 nm and G6PD activity is expressed as G6PD 1Unit/RBCs and G6PD Unit/g haemoglobin ratio when measured at 37 0 c.
The procedure is as follow: 1 ml of reagent R1 was Pipetted pipetted into test tube. Then 0.03 ml of reagent R2 was added. Thereafter, 0.015 ml of haemolysate (test) was added into the tube. It was mixed by inversion and incubated at 37 0 c 37 0 C for 5 minutes. And 0.015 ml of reagent R3 (enzyme substrate) was added to the test tube. It was mixed by inversion and allowed for 5 minutes and finally read spectrophotometrically at wavelength 340 nm
RESULTS
This study was carried out to determine the prevalence of Glucose-6-phosphate dehydrogenase (G6PD) deficiency among the Ogoni and Etche ethnic groups in Rivers State. A total number of 200 subjects were used in the study out of which 100 subjects were from Ogoni and 100 subjects were those from Etche. Out of the 100 subjects from Ogoni 49 were male and 51 were female while out of the 100 subjects from Etche 62 were male and 38 were female as shown in Table 1 . When G6PD level deficiency among Ogoni subject and Etche were compared the result obtained shows the Ogoni subjects had 6.21±0.34Unit/gHb and that of Etche subjects had 5.92±0.54 with both having percentage deficiency of 9% and 13% respectively and the nondeficiency subject at the rate of 91% and 87% respectively with (P = 0.19, t = 1.35) which shows non-significant difference at (P = 0.05). The Prevalence Mean ± SD of G6PD deficiency in percentage base on location of Ogoni and Etche is shown in Table 2 . When Glucose 6-phosphere dehydrogenase level of the test subjects from Ogoni were compared with that of Etche, the result obtained showed that the test of Ogoni had 9.092 ± 1.51 Unit/g Hb and test of Etche had 9.365 ± 2.25 Unit/g Hb (P = 0.317, t = 1.004), which shows no significant difference at (P<0.05). Table 3 Shows the Prevalence of G6PD Deficiency and Non-deficiency in Ogoni and Etche Ethnic Groups. When G6PD level of the test subjects from Ogoni were compared with that Etche subjects, the result obtained shows that the Ogoni male had 6.21±0.32 Unit/gHb and test of Etche male had 6.0±0.54 Unit/gHb (P = 0.41; t = 0.85) which indicates no significant difference at (P< 0.05). Table 4 shows the comparison Mean ±SD of G6PD Deficiency among Ogoni and Etche Male Subjects. 
DISCUSSION
The present study was aimed at determining the prevalence of glucose-6-phosphate dehydrogenase deficiency among Ogoni and Etche ethnic groups in Rivers State. This study, out of the 100% Ogoni and Etche subjects, 9% of Ogonis and 13% of Etches were deficient of the enzyme with non-deficient rate of 91% and 87% respectively among the two groups.
The study showed that out of the 49 male subjects and 57 female subjects from Ogoni, 42 males and 49 females are non-deficient while 7 males and 2 females are deficient with total of 9 subjects being deficient with P = 0.41 for male and P = 0.44 for female at (P = 0.05). In comparison with Etche subjects, the study shows that out of the 62 males subjects and 36 females subjects from Etche 54 males and 33 females are non-deficient while 8 males and 5 females making a total of 13 subjects being deficient, with P = 0.41 for male and P= 0.44 for female, which shows no significant difference at (P= 0.05).
This study was compared to the previous study carried out by [9] on Nigeria children. Where result obtained showed that the odd of G6PD deficiency were 3.6 times higher in males compared to females. This confirms that males were more affected than females as indicated by this study. The findings of this study indicates that G6PD enzyme defect is an X-linked chromosomal inheritance which affects more of male due to the inheritance of X chromosome as the only sex X chromosome while the female having two X-chromosome are less affected.
CONCLUSION
This study confirms that incidence of Glucose-6-Phosphate dehydrogenase (G6PD) deficiency is common among the Etche ethnic group than the Ogoni, although with no significant difference and occur more in male than in female of subjects from these two regions of the population study.
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